Here are five things to know:
1. In controlling the House, Senate and Presidency, Republicans like their chances to permanently repeal the tax in the near future.
2. Device manufacturers have spent roughly $158 million on lobbying in Washington since 2012, according to OpenSecrets.org.
3. AdvaMed hopes to work with tax repeal supporters Reps. Eric Paulsen (R-Minn.) and Ron Kind (D-Wis.) and Sens. Orrin Hatch (R-Utah) and Amy Klobuchar (D-Minn.) to permanently abolish the tax, according to MassDevice.
4. The medical device industry is expected to continue spending millions of dollars lobbying to repeal the tax with or without the AHCA bill, according to the JD Supra report.
5. The 2.3 percent excise tax is schedule to go back into effect on Jan. 1, 2018.
More articles on devices:
Successful meniscus replacement procedures taking place in Colorado — 4 things to know
Global vertebral compression fractures devices market to hit $1.19M by 2022 — 9 observations
Cytokinetics reports Q1 2017 revenue of $4.2M— 5 highlights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
